Advertisement

ASH 2022: Re-evaluating the Standard of Care in Mantle Cell Lymphoma
Posted: 12/13/2022 | By: Kayci Reyer

Results of the randomized Triangle trial in younger patients with mantle cell lymphoma were presented by Dreyling et al at the 2022 ASH Annual Meeting and Exposition (Abstract 1).

Question 1 of 5

In the Triangle trial, patients were randomly assigned to receive one of the following treatments EXCEPT:

Choose 1